| 10 Avril 2018
10 APRIL 2018 | ABUJA, NIGERIA - Nearly one billion  people will be vaccinated against yellow fever in 27 high-risk African  countries by 2026 with support from WHO, Gavi – the Vaccine Alliance,  UNICEF and more than 50 health partners.
 
 The commitment is part of the Eliminate Yellow fever Epidemics (EYE) in  Africa strategy, which was launched by Dr Tedros Adhanom Ghebreyesus,  WHO Director-General, Professor Isaac Folorunso Adewole, Nigeria’s  Minister of Health and partners at a regional meeting in Abuja, Nigeria  on Tuesday (10 April).
 
 "The world is facing an increased risk of Yellow fever outbreaks and  Africa is particularly vulnerable," said Dr Tedros. "With one injection  we can protect a person for life against this dangerous pathogen. This  unprecedented commitment by countries will ensure that by 2026 Africa is  free of Yellow fever epidemics."
 
 During the three-day EYE strategy regional launch meeting  representatives from key African countries, WHO, UNICEF, Gavi, and other  partners are developing a roadmap on how to roll-out the EYE strategy  at national level. This implementation effort follows the endorsement of  the strategy by African Ministers of Health at the 67th WHO regional  committee in September 2017.
 
 "This comprehensive, global strategy offers an unprecedented opportunity  to end the devastating Yellow fever epidemics that periodically impact  Africa," said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.  "Ensuring that the most vulnerable communities have access to the  vaccine through routine systems plays a central role in making this  happen. Vaccine manufacturers and Gavi partners have worked hard to  improve the global vaccine supply situation in recent years to make sure  there is enough vaccine to respond to outbreaks, allow preventive  campaigns and that routine immunization functions at full capacity."
 
 The three objectives of the strategy include protecting at-risk  populations through preventive mass vaccination campaigns and routine  immunization programmes, preventing international spread, and containing  outbreaks rapidly. Developing strong surveillance with robust  laboratory networks is key to these efforts.
 
 UNICEF will make vaccines available, advocate for greater political  commitment and provide support in vaccinating children through routine  immunization as well as during outbreaks of the disease.
 
 "Today, the threat of yellow fever looms larger than ever before,  especially for thousands of children across Africa," said Stefan  Peterson, UNICEF’s Chief of Health. "Given that almost half of the  people to be vaccinated are children under 15 years of age, this  campaign is critical to saving children’s lives, and would go a long way  toward stamping out this disease."
 
 After outbreaks of Yellow fever in densely populated cities in Angola  and the Democratic Republic of Congo caused 400 deaths in 2016, the  acute viral haemorrhagic disease re-emerged as a serious global public  health threat. Brazil is currently battling its worst outbreak of Yellow  fever in decades with more than 1,000 confirmed cases. The ease and  speed of population movements, rapid urbanization and a resurgence of  mosquitoes due to global warming have significantly increased the risk  of urban outbreaks with international spread.
 
 Experience in West Africa demonstrates that the EYE strategy can work.  When Yellow fever re-emerged as a public health issue in the early  2000s, countries in the region controlled the epidemics through  preventive mass campaigns combined with routine immunization. No yellow  fever epidemics have been recorded since in countries which successfully  implemented this approach.









